
IndraLab
Statements
reach
"Using a pharmacological tool compound R-L3 (L-364,373 [(3-R) -1,3-dihydro-5-(2-fluorophenyl)-3-(1H-indol- 3-ylmethyl)-1-methyl-2H-1,4-benzodiazepin-2-one]), which activates KCNQ1 and mink channels, we then developed and validated a non radioactive rubidium (Rb+) efflux assay that directly measures the functional activity of KCNQ1 and KCNE1 channels by atomic absorption spectroscopy."